UnknownPhase 2NCT03619824

PD-1 Blockade Combined With Definitive Chemoradiation in Locoregionally-advanced Nasopharyngeal Carcinoma

Studying Anorectal malformation

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sun Yat-sen University
Principal Investigator
Jun Ma
Sun Yat-Sen University Cancer Center
Intervention
Sintilimab(drug)
Enrollment
40 target
Eligibility
18-65 years · All sexes
Timeline
20192024

Study locations (1)

Collaborators

Innovent Biologics (Suzhou) Co. Ltd.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03619824 on ClinicalTrials.gov

Other trials for Anorectal malformation

Additional recruiting or active studies for the same condition.

See all trials for Anorectal malformation

← Back to all trials